2025
Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management
Wahood S, Alani O, Draw I, Shqair L, Wang D, Bunick C, Damiani G, Ho J, Obagi S, Akbarialiabad H, Galimberti F, Ghannoum M, Grada A. Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management. Pharmaceuticals 2025, 18: 800. PMID: 40573197, PMCID: PMC12196204, DOI: 10.3390/ph18060800.Peer-Reviewed Original ResearchSoft tissue infectionsTissue infectionsMultidrug-resistant Gram-negative organismsRisk of torsade de pointesClinical useLiterature search of PubMedResistant to ciprofloxacinComplicated skin infectionsHigh-risk patientsQT interval prolongationCorrected QT intervalShort treatment courseGram-negative organismsPatient risk factorsSearch of PubMedBacterial skinOral fluoroquinolonesInterval prolongationTreatment courseOral formulationResistance patternsCure rateQT intervalTopical treatmentSkin infections16 Resource Allocation: Costs and Length of Stay for Non-Burn Patient in Burn Center
Usman M, Savetamal A. 16 Resource Allocation: Costs and Length of Stay for Non-Burn Patient in Burn Center. Journal Of Burn Care & Research 2025, 46: s13-s14. PMCID: PMC11958293, DOI: 10.1093/jbcr/iraf019.016.Peer-Reviewed Original ResearchNon-burn patientsLength of stayDiverse patient populationsBurn patientsPatient populationBurn centerNecrotizing soft tissue infectionStevens-Johnson syndrome/toxic epidermal necrolysisSoft tissue infectionsEnhance patient outcomesHigh-level careElectronic medical recordsBurn care settingNon-burn injuryHigh-quality treatmentSoft tissue injuriesCare settingsSoft tissue pathologyCare efficiencyTissue infectionsStratify patientsHospital stayFournier's gangreneEpidermal necrolysisRetrospective analysisCFTR dictates monocyte adhesion by facilitating integrin clustering but not activation
Younis D, Marosvari M, Liu W, Pulikkot S, Cao Z, Zhou B, Vella A, McArdle S, Hu L, Chen Y, Gan W, Yu J, Bruscia E, Fan Z. CFTR dictates monocyte adhesion by facilitating integrin clustering but not activation. Proceedings Of The National Academy Of Sciences Of The United States Of America 2025, 122: e2412717122. PMID: 39813254, PMCID: PMC11760921, DOI: 10.1073/pnas.2412717122.Peer-Reviewed Original ResearchConceptsIntegrin clusteringCF transmembrane conductance regulatorCystic fibrosisAdhesion defectsPathogenesis of cystic fibrosisClinically relevant disease modelsMembrane recruitmentTransmembrane conductance regulatorIntegrin activationTherapeutic strategy designRelevant disease modelsIntegrinCF monocytesCell adhesionMonocyte dysfunctionPatients' monocytesTissue infectionsConductance regulatorSuperresolution microscopyCortex formationLeukocyte-dependent inflammationInflammatory pathogenesisLeukocyte adhesionMonocytesInflammation
2024
Effect of empiric antibiotics against Pseudomonas aeruginosa on mortality in hospitalized patients: a systematic review and meta-analysis
Hunter C, Marhoffer E, Holleck J, Alshaeba S, Grimshaw A, Chou A, Carey G, Gunderson C. Effect of empiric antibiotics against Pseudomonas aeruginosa on mortality in hospitalized patients: a systematic review and meta-analysis. Journal Of Antimicrobial Chemotherapy 2024, 80: 322-333. PMID: 39656468, DOI: 10.1093/jac/dkae422.Peer-Reviewed Original ResearchPrevalence of P. aeruginosaEffects of empiric antibioticsEmpirical antibioticsUrinary tract infectionSoft tissue infectionsCommunity-acquired pneumoniaTract infectionsTissue infectionsP. aeruginosaMortality benefitHospitalized patientsPseudomonas aeruginosaPooled adjusted ORP. aeruginosa infectionType of infectionStudy of patientsAbsolute mortality benefitIntensive care settingSystematic literature searchNosocomial pneumoniaSeptic shockMeaningful benefitAdjusted ORWeb of ScienceCompare mortality ratesExperience with expanded use of oritavancin in a tertiary hospital: indications, tolerability and outcomes
Bandaranayake T, Radcliffe C, Cvercko M, Golden M, Hao R. Experience with expanded use of oritavancin in a tertiary hospital: indications, tolerability and outcomes. JAC-Antimicrobial Resistance 2024, 6: dlae174. PMID: 39493938, PMCID: PMC11524893, DOI: 10.1093/jacamr/dlae174.Peer-Reviewed Original ResearchDose of oritavancinInfective endocarditisTreatment of acute bacterial skinBacterial infectionsLipoglycopeptide antibacterial agentTertiary care medical centreAcute bacterial skinGram-positive bacterial infectionsInvasive bacterial infectionsTreatment failure rateNinety-five adult patientsSoft tissue infectionsProsthetic joint infectionGram-positive organismsBacterial skinDrug discontinuationTissue infectionsRetrospective studyAdult patientsClinical outcomesAdverse eventsOritavancinOff-labelJoint infectionTreat infectionsThe Use of Postoperative Antibiotics in Shoulder Arthroscopy Patients.
Vasavada K, Gipsman A, Mojica E, Shankar D, Mannino B, Jazrawi L. The Use of Postoperative Antibiotics in Shoulder Arthroscopy Patients. Bulletin Of The NYU Hospital For Joint Disease 2024, 82: 167-171. PMID: 39150869.Peer-Reviewed Original ResearchConceptsProphylactic oral antibioticsIncidence of infectionShoulder arthroscopyAntibiotic prophylaxisPostoperative antibioticsOral antibioticsAntibiotic usageProphylactic postoperative antibioticsShoulder arthroscopy patientsPostoperative antibiotic prophylaxisDeep tissue infectionsClinical ModificationCases of infectionOutpatient surgery centerRisk of infectionChi-square testRetrospective reviewTissue infectionsInternational Classification of DiseasesPost hoc power analysisArthroscopy patientsPrimary outcomeClassification of DiseasesSurgery centersPatientsFever and infections in surgical intensive care: an American Association for the Surgery of Trauma Critical Care Committee clinical consensus document
Nohra E, Appelbaum R, Farrell M, Carver T, Jung H, Kirsch J, Kodadek L, Mandell S, Nassar A, Pathak A, Paul J, Robinson B, Cuschieri J, Stein D. Fever and infections in surgical intensive care: an American Association for the Surgery of Trauma Critical Care Committee clinical consensus document. Trauma Surgery & Acute Care Open 2024, 9: e001303. PMID: 38835635, PMCID: PMC11149120, DOI: 10.1136/tsaco-2023-001303.Peer-Reviewed Original ResearchAmerican Association for the SurgeryIntensive care unitClinical consensus documentCatheter-associated urinary infectionDuration of antibiotic treatmentCatheter-related bloodstream infectionNecrotizing soft tissue infectionConsensus documentWorkup of feverIntra-abdominal infectionsSurgical intensive care unitSoft tissue infectionsEvaluation of feverSurgical site infectionVentilator-associated pneumoniaDiagnosis of infectionSurgical intensive careEmpirical antibioticsBloodstream infectionsRespiratory specimensUrinary infectionTissue infectionsSite infectionAntibiotic treatmentTreat infectionsA Cross-Sectional Analysis of Pediatric Necrotizing Soft Tissue Infection Cases and Racial Disparities From the 2016 to 2020 National Inpatient Sample
Hamid S, Graetz E, Schneider E, Gibbs K. A Cross-Sectional Analysis of Pediatric Necrotizing Soft Tissue Infection Cases and Racial Disparities From the 2016 to 2020 National Inpatient Sample. Journal Of Surgical Research 2024, 297: 136-143. PMID: 38518580, DOI: 10.1016/j.jss.2024.02.009.Peer-Reviewed Original ResearchConceptsBlack patientsNecrotizing fasciitisOutcomes of necrotizing soft tissue infectionsPediatric populationSoft-tissue infection casesWhite patientsRacial disparitiesDiagnosis of necrotizing fasciitisNSTI casesSoft tissue infectionsProportion of black patientsNational Inpatient SamplePostoperative complicationsTissue infectionsFournier's gangreneSurgical proceduresCross-sectional analysisInfection overallPatientsHispanic patientsInpatient SampleNSTIMortality rateSubcutaneous tissueFasciitisScientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease
Armillei M, Lomakin I, Del Rosso J, Grada A, Bunick C. Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease. Antibiotics 2024, 13: 270. PMID: 38534705, PMCID: PMC10967556, DOI: 10.3390/antibiotics13030270.Peer-Reviewed Original ResearchSoft tissue infectionsTetracycline class antibioticsTreatment of dermatological diseasesMechanism of protein synthesis inhibitionClindamycin useStaphylococcal infectionsTissue infectionsClinical presentationAnti-inflammatory propertiesHidradenitis suppurativaEffective antibioticsTreatment optionsClindamycinClinical evidenceAcne vulgarisClinical basisProtein synthesis inhibitionDermatological indicationsAmeliorate inflammationAntibiotic resistanceDermatology practiceBacterial ribosomeDermatological diseasesClass antibioticsLesion formationGuide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) ∗
Miller J, Binnicker M, Campbell S, Carroll K, Chapin K, Gonzalez M, Harrington A, Jerris R, Kehl S, Leal S, Patel R, Pritt B, Richter S, Robinson-Dunn B, Snyder J, Telford S, Theel E, Thomson R, Weinstein M, Yao J. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) ∗. Clinical Infectious Diseases 2024, ciae104. PMID: 38442248, DOI: 10.1093/cid/ciae104.Peer-Reviewed Original ResearchInfectious Diseases Society of AmericaSoft tissue infectionsTissue infectionsTract infectionsMicrobiology laboratoryCentral nervous system infectionLower Respiratory Tract InfectionsUrinary tract infectionHead and neckInfectious Diseases SocietyNervous system infectionRespiratory tract infectionsTissue parasite infectionsUpper respiratory infectionAmerican Society for MicrobiologyProlonged turnaround timeInfectious diseasesTests to orderGenital infectionIntraabdominal infectionsBloodstream infectionsOcular infectionsDiagnosis of infectious diseasesViral syndromeJoint infection
2023
Characterizing skin and soft tissue infections in patients with cancer on systemic oncologic therapy: A single institution retrospective analysis from the outpatient and inpatient oncodermatology service
Pach J, Nelson C, Leventhal J. Characterizing skin and soft tissue infections in patients with cancer on systemic oncologic therapy: A single institution retrospective analysis from the outpatient and inpatient oncodermatology service. JAAD International 2023, 15: 21-23. PMID: 38371669, PMCID: PMC10869938, DOI: 10.1016/j.jdin.2023.11.011.Peer-Reviewed Original ResearchRacial and Ethnic Differences Among Adult Patients Hospitalized for Skin and Soft Tissue Infection: A Cross-Sectional Analysis of 2012-2017 New York State Data.
Sedghi T, Cohen J, Feng H. Racial and Ethnic Differences Among Adult Patients Hospitalized for Skin and Soft Tissue Infection: A Cross-Sectional Analysis of 2012-2017 New York State Data. The Journal Of Clinical And Aesthetic Dermatology 2023, 16: 19-21. PMID: 38076657, PMCID: PMC10703506.Peer-Reviewed Original ResearchSoft tissue infectionsEthnic differencesStructural vulnerabilityHealthcare accessTissue infectionsAdult patientsNew York StateEthnic disparitiesDisparitiesEthnic minority patientsCost of hospitalizationLength of staySeverity of illnessIncreased healthcare costsClinical outcomesCross-sectional analysisWhite patientsPatientsInvestigate such differencesNewClinical presentation of group B Streptococcus-infected diabetic foot ulcers
Waldman O, Dexter B, Sulovari A, Oh I. Clinical presentation of group B Streptococcus-infected diabetic foot ulcers. Journal Of Wound Care 2023, 32: s19-s25. PMID: 37405964, DOI: 10.12968/jowc.2023.32.sup7.s19.Peer-Reviewed Original ResearchConceptsDiabetic foot ulcersFoot ulcersBlack patientsRecurrent infectionsElevated hemoglobin A1cIntra-operative culturesHemoglobin A1c levelsInitial laboratory valuesSoft tissue infectionsDFU infectionsDFU patientsInitial surgeryOrthopaedic FootAggressive treatmentClinical characteristicsGBS infectionA1c levelsHemoglobin A1cTissue infectionsClinical outcomesClinical presentationInfected boneAppropriate treatmentGroup BLaboratory valuesPatterns of Infectious Disease Associated With Injection Drug Use in Massachusetts
Gonsalves G, Paltiel A, Thornhill T, DeMaria A, Cranston K, Klevens R, Warren J. Patterns of Infectious Disease Associated With Injection Drug Use in Massachusetts. Clinical Infectious Diseases 2023, 76: 2134-2139. PMID: 36757712, PMCID: PMC10273381, DOI: 10.1093/cid/ciad073.Peer-Reviewed Original ResearchConceptsSoft tissue infectionsHuman immunodeficiency virusHepatitis C virusInjection drug useHCV casesInfective endocarditisHIV casesDrug useSubstance use disordersLogistic regression modelsClinical sequalaeSSTI casesPublic health crisisTissue infectionsImmunodeficiency virusDisease AssociatedHIV outbreakAbscess incisionC virusUse disordersInfectious diseasesInfectionMultiple outbreaksMedical proceduresSuch associations
2022
Concurrent targeting of glycolysis in bacteria and host cell inflammation in septic arthritis
Kwon H, Yu K, Cahill S, Alder K, Dussik C, Kim S, Sharma L, Back J, Oh I, Lee F. Concurrent targeting of glycolysis in bacteria and host cell inflammation in septic arthritis. EMBO Molecular Medicine 2022, 14: emmm202115284. PMID: 36354099, PMCID: PMC9728052, DOI: 10.15252/emmm.202115284.Peer-Reviewed Original ResearchConceptsDrug dimethyl fumarateSeptic arthritisIntracellular MRSABacterial joint infectionSoft tissue infectionsAnti-inflammatory effectsInfection-associated inflammationNovel therapeutic paradigmContext of infectionConventional antibiotic treatmentHost cellsAdjuvant administrationSurgical treatmentTissue infectionsClinical symptomsInflammatory machineryJoint infectionBacterial burdenAntibiotic treatmentCell inflammationHost inflammationArthritisInflammationIntraarticular inflammationTherapeutic paradigmStenotrophomonas maltophilia, a Pathogen of Increasing Relevance to Dermatologists: A Case Report and Review of the Literature
Belzer A, Weiss E, Etaee F, Bunick CG, Damsky W, Nelson CA. Stenotrophomonas maltophilia, a Pathogen of Increasing Relevance to Dermatologists: A Case Report and Review of the Literature. Antibiotics 2022, 11: 1398. PMID: 36290055, PMCID: PMC9598652, DOI: 10.3390/antibiotics11101398.Peer-Reviewed Original ResearchSoft tissue infectionsUrinary tract infectionChronic lymphocytic leukemiaGram-negative bacilliTract infectionsImmunocompetent populationTissue infectionsHigh morbidityAplastic anemiaCase reportLymphocytic leukemiaInfectionBacteremiaCurrent standardStenotrophomonas maltophiliaDermatologistsLimited optionsMorbidityPneumoniaPatientsAnemiaTherapyLeukemiaMortalityPrevalenceDematiaceous fungal infections in solid organ transplantation: Systematic review and Bayesian meta‐analysis
Radcliffe C, Radcliffe AJ, Azar MM, Grant M. Dematiaceous fungal infections in solid organ transplantation: Systematic review and Bayesian meta‐analysis. Transplant Infectious Disease 2022, 24: e13819. PMID: 35253959, DOI: 10.1111/tid.13819.Peer-Reviewed Original ResearchConceptsSolid organ transplant recipientsDematiaceous fungal infectionSoft tissue infectionsFungal infectionsInfectious syndromesSystematic reviewEarly post-transplant periodCentral nervous system infectionCommon infectious syndromesPost-transplant periodNervous system infectionOrgan transplant recipientsSolid organ transplantationEnglish-language reportsInfection typeKidney recipientsLiver recipientsPediatric reportsTransplant recipientsPulmonary infectionSystem infectionTissue infectionsWorse prognosisDisseminated infectionMean age
2021
The Dynamics of Infectious Diseases Associated With Injection Drug Use in Lawrence and Lowell, Massachusetts
Gonsalves GS, Paltiel A, Thornhill T, Iloglu S, DeMaria A, Cranston K, Klevens R, Walensky RP, Warren JL. The Dynamics of Infectious Diseases Associated With Injection Drug Use in Lawrence and Lowell, Massachusetts. Open Forum Infectious Diseases 2021, 8: ofab128. PMID: 34189158, PMCID: PMC8231383, DOI: 10.1093/ofid/ofab128.Peer-Reviewed Original ResearchInjection drug useDrug useHuman immunodeficiency virus (HIV) outbreaksInfectious diseasesSoft tissue infectionsCases of skinPublic health departmentsPoisson regression modelsInfectious complicationsTissue infectionsHIV casesDrainage proceduresFatal overdosesHealth departmentsComplicationsEarly interventionMonthsPotential outbreaksVirus outbreakSentinel SystemDiseaseRegression modelsOutbreakHIVOverdoses
2020
Mycobacterium marinum: nodular hand lesions after a fishing expedition
Tuan J, Spichler-Moffarah A, Ogbuagu O. Mycobacterium marinum: nodular hand lesions after a fishing expedition. BMJ Case Reports 2020, 13: e238835. PMID: 33318281, PMCID: PMC7737068, DOI: 10.1136/bcr-2020-238835.Peer-Reviewed Case Reports and Technical NotesConceptsSoft tissue infectionsDeep space infectionsTissue infectionsSpace infectionAcid-fast bacilliTreatment of skinNon-tuberculous mycobacteriaTerms of treatmentDisseminated diseaseOptimal regimenHand lesionsMedical managementExtremity lesionsCombination therapyInfectionLesionsAddition of rifampicinFurther dataSkinTreatmentMycobacteriaOsteomyelitisRegimenPatientsSurgeryNecrotizing Soft Tissue Infections of the Upper Extremity
Melillo A, Addagatla K, Jarrett N. Necrotizing Soft Tissue Infections of the Upper Extremity. Hand Clinics 2020, 36: 339-344. PMID: 32586460, DOI: 10.1016/j.hcl.2020.03.007.Peer-Reviewed Original ResearchConceptsNecrotizing soft tissue infectionSoft tissue infectionsTissue infectionsUpper extremityIntravenous drug useRate of amputationLoss of limb or lifePeripheral arterial diseaseImmunocompromised stateClinical examinationDiabetes mellitusAntimicrobial treatmentDecreased riskArtery diseaseRisk factorsAlcohol abuseDrug useInfectionDiagnosisLaboratory testsTreatment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply